Dr Reddys Laboratories (RDY) Net Income Growth (5y) (2014 - 2023)
Dr Reddys Laboratories (RDY) Net Income Growth (5y) (2014 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.78 Bn | 87.91 Bn | - |
| 2 | Teva Pharmaceutical Industries | 36.02 Bn | 32.28 Bn | 1.97 Bn |
| 3 | Zoetis | 32.60 Bn | 30.66 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.94 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.35 Bn | 18.54 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.82 Bn | 16.50 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn |
| 10 | Dr Reddys Laboratories | 9.85 Bn | 9.69 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 20.83% |
| Mar 31, 2023 | 22.25% |
| Dec 31, 2022 | 21.60% |
| Sep 30, 2022 | -92.21% |
| Mar 31, 2021 | -3.71% |
| Sep 30, 2020 | -26.52% |
| Jun 30, 2020 | -1.12% |
| Sep 30, 2019 | -7.05% |
| Mar 31, 2019 | 9.22% |
| Dec 31, 2018 | -7.89% |
| Sep 30, 2018 | -17.40% |
| Jun 30, 2018 | -59.67% |
| Mar 31, 2018 | 0.65% |
| Dec 31, 2017 | -15.97% |
| Sep 30, 2017 | -10.64% |
| Dec 31, 2016 | -63.57% |
| Sep 30, 2016 | -61.99% |
| Mar 31, 2016 | 11.49% |
| Dec 31, 2015 | -8.72% |
| Sep 30, 2015 | 20.84% |